Germany
Japan
United Kingdom
China
Frizzled 2 (FZD2) goat polyclonal antibody, Aff - Purified
| Applications | ELISA, IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Immunogen | Peptide with sequence from the internal region of the protein sequence according to NP_001457.1. |
Research Areas
View as table Download
Goat Polyclonal Anti-ROR1 Antibody
| Applications | IHC |
| Reactivities | Human (Expected from sequence similarity: Mouse, Rat) |
| Conjugation | Unconjugated |
| Immunogen | The immunogen for Anti-ROR1 Antibody: Peptide with sequence C-GNKSQKPYKIDSKQA, from the C-Terminus (near) of the protein sequence according to NP_005003.2. |
IL6 goat polyclonal antibody, Aff - Purified
| Applications | ELISA, FN, IHC, WB |
| Reactivities | Human |
| Immunogen | Highly pure (> 98%), 20.9 kDa E.coli derived recombinant Human IL-6 |
IL6 goat polyclonal antibody, Aff - Purified
| Applications | ELISA, FN, IHC, WB |
| Reactivities | Human |
| Immunogen | Highly pure (> 98%), 20.9 kDa E.coli derived recombinant Human IL-6 |
LRP6 (Internal) goat polyclonal antibody, Aff - Purified
| Applications | ELISA, IHC |
| Reactivities | Canine, Equine, Hamster, Human, Monkey, Porcine, Rabbit, Rat |
| Immunogen | Synthetic peptide from an internal region of human LRP6 (NP_002327.2) |
Il1a goat polyclonal antibody, Aff - Purified
| Applications | ELISA, FN, IHC, WB |
| Reactivities | Rat |
| Immunogen | Recombinant rat IL-1 alpha |
Il1a goat polyclonal antibody, Aff - Purified
| Applications | ELISA, FN, IHC, WB |
| Reactivities | Rat |
| Immunogen | Recombinant rat IL-1 alpha |
Apolipoprotein CII (APOC2) goat polyclonal antibody, Purified
| Applications | ELISA, IHC, IP, WB |
| Reactivities | Human |
| Immunogen | ApoLipoprotein Type C-II produced synthetically in full-length form (not selected epitopes) using conventional peptide technology |
Anti-ROR1 Goat Polyclonal () Antibody
| Applications | IHC |
| Reactivities | Gibbon, Gorilla, Human |
| Conjugation | Unconjugated |
| Immunogen | ROR1 antibody was raised against synthetic peptide C-GNKSQKPYKIDSKQA from the C-terminus (near) of human ROR1 (NP_005003.2). Percent identity by BLAST analysis: Human, Gorilla, Gibbon (100%); Monkey, Marmoset, Mouse, Rat, Hamster, Elephant, Panda, Dog, Bat, Bovine, Horse, Rabbit, Lizard (93%); Turkey, Chicken (87%); Platypus (80%). |
HLA-DQA2 goat polyclonal antibody, Aff - Purified
| Applications | ELISA, IHC, WB |
| Reactivities | Human |
| Immunogen | Peptide with sequence from the internal region of the protein sequence according to NP_064440.1. |
Frizzled 9 (FZD9) goat polyclonal antibody, Aff - Purified
| Applications | ELISA, IHC |
| Reactivities | Human, Mouse, Rat |
| Immunogen | Peptide with sequence from the C Terminus of the protein sequence according to NP_003499.1. |
Goat Anti-LRP6 Antibody
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence CMTSVATAKGYTSDL, from the internal region of the protein sequence according to NP_002327.2. |
Goat Anti-LRP5 Antibody
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence C-ERVEKTTGDKRT, from the internal region of the protein sequence according to NP_002326.2. |
Goat Anti-FZD4 Antibody
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence C-KIRSNLQKDGTKT, from the internal region of the protein sequence according to NP_036325.2. |
Active filters
Applications
- IHC
Antibody Hosts
- Goat
Clonalities
- Polyclonal
Filter by
Category
Target Symbol
Reactivities
Isotypes
Conjugates
Families
Pathways
- Pathways in cancer (9)
- Wnt signaling pathway (8)
- Basal cell carcinoma (6)
- Melanogenesis (6)
- Colorectal cancer (4)
- Toll-like receptor signaling pathway (4)
- Cytokine-cytokine receptor interaction (3)
- Hematopoietic cell lineage (3)
- Jak-STAT signaling pathway (3)
- Cytosolic DNA-sensing pathway (2)
- Graft-versus-host disease (2)
- Hedgehog signaling pathway (2)
- Hypertrophic cardiomyopathy (HCM) (2)
- MAPK signaling pathway (2)
- NOD-like receptor signaling pathway (2)
- Prion diseases (2)
- RIG-I-like receptor signaling pathway (2)
- Adipocytokine signaling pathway (1)
- Allograft rejection (1)
- Apoptosis (1)
- Cell adhesion molecules (CAMs) (1)
- Pathogenic Escherichia coli infection (1)
- Regulation of actin cytoskeleton (1)
- Small cell lung cancer (1)
- Type I diabetes mellitus (1)